{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:38:17Z","timestamp":1793860697727,"version":"4.6.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"\n Background:<\/jats:title>\n Polycystic ovary syndrome (PCOS) is the most common female endocrine disorder with unknown etiology and with different complications. The aim of this study was to evaluate the effect of omega-3 supplementation on PCOS symptoms and metabolic syndrome.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n This double-blind clinical trial was performed in 2015 in Alzahra and Shahid Beheshti Hospitals, Isfahan, Iran, on 88 patients with PCOS. Intervention group took omega-3 supplements with dose of 2 g\/day for 6 months (two capsules), but control group received two olive oil capsules. Finally, ultrasound and laboratory findings and the recovery rate of menstrual disorders in both groups were compared.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n After 6 months\u2019 intervention, waist circumference (WC) was significantly lower in omega-3 as compared to control (81.18 \u00b1 2.87 vs. 84.22 \u00b1 2.61 cm, respectively,\n P<\/jats:italic>\n < 0.0001). High-density lipoprotein was increased (47.2 \u00b1 1.37 vs. 41.56 \u00b1 1.34 mg\/dl, respectively,\n P<\/jats:italic>\n < 0.0001) while low-density lipoprotein (107.79 \u00b1 1.68 vs. 117.4 \u00b1 1.57 mg\/dl, respectively), triglyceride (116.02 \u00b1 3.13 vs. 125.06 \u00b1 2.91 mg\/dl, respectively), and cholesterol (180.34 \u00b1 6.34 vs. 189.56 \u00b1 5.93 mg\/dl, respectively) in omega-3 were significantly lower than control (\n P<\/jats:italic>\n < 0.0001). The interval between periods in omega-3 was significantly shorter than control (29.83 \u00b1 4.68 vs. 47.11 \u00b1 8.72 days, respectively,\n P<\/jats:italic>\n < 0.001).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Omega-3 decrease lipid profiles, WC, and interval between periods while weight, hip circumference, fasting blood sugar, number of ovarian follicle, size of ovary, bleeding volume, menstrual bleeding, and hirsutism score did not change by administration of omega-3.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/jrms.jrms_644_16","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T05:08:44Z","timestamp":1496120924000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":43,"title":["Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome"],"prefix":"10.4103","volume":"22","author":[{"given":"Behnaz","family":"Khani","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farahnaz","family":"Mardanian","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajadeh Jafari","family":"Fesharaki","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"R1-20250827","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jsbmb.2009.12.010","article-title":"Insulin and hyperandrogenism in women with polycystic ovary syndrome","volume":"122","author":"Baptiste","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R2-20250827","first-page":"14172","article-title":"Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"20","author":"Kelley","year":"2014","journal-title":"stroenterol"},{"key":"R3-20250827","doi-asserted-by":"crossref","first-page":"E375","DOI":"10.1152\/ajpendo.00491.2012","article-title":"Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome","volume":"304","author":"Gonz\u00e1lez","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R4-20250827","first-page":"297","article-title":"Effect of soy phytoestrogen on metabolic and hormonal disturbance of women with polycystic ovary syndrome","volume":"16","author":"Khani","year":"2011","journal-title":"J Res Med Sci"},{"key":"R5-20250827","first-page":"238","article-title":"The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria","volume":"62","author":"Mehrabian","year":"2011","journal-title":"Endokrynol Pol"},{"key":"R6-20250827","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1472-6483(10)60175-7","article-title":"Polycystic ovary syndrome and the risk of gynaecological cancer: A systematic review","volume":"19","author":"Chittenden","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"R7-20250827","first-page":"538","article-title":"Investigating validity criteria of vaginal ultrasound (ovarian volume, the ovarian stroma and the stromal surface of the ovary) in the diagnosis of polycystic ovary syndrome","volume":"3","author":"Haji Shafiha","year":"2007","journal-title":"Urmia Med J"},{"key":"R8-20250827","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: An Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-20250827","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertil Steril"},{"key":"R10-20250827","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"key":"R11-20250827","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology And Adverse Cardiovascular Risk Profile Of Diagnosed Polycystic Ovary Syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-20250827","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3945\/ajcn.110.005538","article-title":"Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: Results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial","volume":"93","author":"Phelan","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"R13-20250827","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/07315724.2012.10720443","article-title":"Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome","volume":"31","author":"Rafraf","year":"2012","journal-title":"J Am Coll Nutr"},{"key":"R14-20250827","doi-asserted-by":"crossref","first-page":"A22","DOI":"10.1111\/j.0959-9673.2004.369ab.x","article-title":"Effects of n-3 polyunsaturated fatty acids on COX-2 and PGE2 protein levels in articular cartilage chondrocytes","volume":"85","author":"Hurst","year":"2004","journal-title":"Int J Exp Pathol"},{"key":"R15-20250827","doi-asserted-by":"crossref","first-page":"27i","DOI":"10.1016\/j.amjcard.2005.12.024","article-title":"Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids","volume":"98","author":"Davidson","year":"2006","journal-title":"Am J Cardiol"},{"issue":"1 Suppl","key":"R16-20250827","doi-asserted-by":"crossref","first-page":"228S","DOI":"10.1093\/ajcn\/71.1.228S","article-title":"Fish oil and cardiovascular disease: Lipids and arterial function","volume":"71","author":"Nestel","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"R17-20250827","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1210\/jc.2009-0870","article-title":"Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: A randomized controlled trial employing proton magnetic resonance spectroscopy","volume":"94","author":"Cussons","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-20250827","article-title":"Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials","author":"Sadeghi","year":"2016","journal-title":"Diabetes Metab Syndr"},{"key":"R19-20250827","first-page":"511","article-title":"Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome","volume":"21","author":"Mohammadi","year":"2012","journal-title":"Asia Pac J Clin Nutr"},{"key":"R20-20250827","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.fertnstert.2005.01.085","article-title":"Diagnostic criteria for polycystic ovary syndrome: A reappraisal","volume":"83","author":"Azziz","year":"2005","journal-title":"Fertil Steril"},{"key":"R21-20250827","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.metabol.2011.04.007","article-title":"Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome","volume":"60","author":"Vargas","year":"2011","journal-title":"Metabolism"},{"key":"R22-20250827","first-page":"490","article-title":"The effect of omega-3 on the serum visfatin concentration in patients with type II diabetes","volume":"16","author":"Hajianfar","year":"2011","journal-title":"J Res Med Sci"},{"key":"R23-20250827","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/ajcn\/76.5.1007","article-title":"Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension","volume":"76","author":"Woodman","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"R24-20250827","first-page":"665","article-title":"The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trial","volume":"11","author":"Nadjarzadeh","year":"2013","journal-title":"Iran J Reprod Med"}],"container-title":["Journal of Research in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01222967-201722000-00064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:22:09Z","timestamp":1787836929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01222967-201722000-00064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/jrms.jrms_644_16","relation":{},"ISSN":["1735-1995","1735-7136"],"issn-type":[{"value":"1735-1995","type":"print"},{"value":"1735-7136","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"2016-09-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-02-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}